# A5 Laboratories Inc. — Form D

A5 Laboratories Inc. of LACHINE, A8, a company, filed a Form D exempt-offering notice with the SEC on 2011-03-11. The offering totals $2.5M, of which $545K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-03-11
- Form: D
- Accession: 0001144204-11-014134
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.5M
- Amount sold: $545K
- Remaining: $2.0M
- Minimum investment: $200K
- Investors: 1
- Date of first sale: 2011-02-23
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-156543

## Issuer

- Name: A5 Laboratories Inc.
- CIK: 0001381054
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2006
- Address: 10300 CHEMIN COTE DE LIESSE, LACHINE, A8, H8T1A3
- Phone: (514) 420-0333

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Richard Azani | Director | Lachina, A8 |
| Richard Azani | Executive Officer | Lachina, A8 |

## More

- [CIK 1381054 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1381054&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001144204-11-014134.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.